The First Workshop of the European Consortium on Charcot-Marie-Tooth (CMT) disease brought together neuroscientists, molecular and cell biologists, neuropathologists, neurologists, and geneticists with a common interest in the understanding of the fundamental mechanisms that underlie the pathogenesis of CMT. The interdisciplinary group of 25 expert scientists discussed recent advances in (i) molecular genetics and histopathology of CMT, (ii) development of suitable animal models, (iii) understanding of the cellular function of CMT-related proteins, and (iv) studies using nerve biopsies from CMT patients. In this minireview, we summarize the key findings presented and discuss their impact on CMT research.
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GENETICS AND HISTOPATHOLOGY

Molecular genetics
CMT1 is genetically heterogeneous and has been shown to be associated with at least four distinct chromosomal loci, providing the genetic rationale for a classification of CMT1 disease forms (for review see De Jonghe et al., 1997) . CMT1 genes have been identified on chromosomes 17 (CMT1A, hereditary neuropathy with liability to pressure palsies (HNPP)), 1 (CMT1B), and X (CMTX). The most common form, CMT1A, is predominantly associated with a 1.5-Mb duplication that appears to arise from unequal recombination at repeat sequences of insect origin and includes the gene of the peripheral myelin protein PMP22 (Suter & Snipes, 1993) . Deletion of the same chromosomal region that is duplicated in CMT1A is the most frequent genetic defect causing HNPP. The duplication and deletion frequencies in CMT1 or HNPP patients were estimated by the European CMT Consortium to be approximately 71 and 84%, respectively (Nelis et al., 1996) .
Thus far, 12 point mutations (9 missense, 1 frame shift, and 2 splice site mutations) have been identified 1 To whom correspondence should be addressed at Laboratorium fü r Molekulare Neurobiologie, Neurologie, Heinrich-Heine-Universität, Moorenstrasse 5, D-40225 Dü sseldorf, Deutschland. Fax: ϩ49 211 811 8411. E-mail: mueller@neurologie.uni-duesseldorf.de. 215-220 (1997) Article No. NB970148
Neurobiology of Disease 4,
